Sakamoto, Akira
Inoue, Hiroyuki
Miyamoto, Shohei
Ito, Shun
Soda, Yasushi
Tani, Kenzaburo
Article History
Received: 12 October 2022
Accepted: 7 April 2023
First Online: 12 April 2023
Competing interests
: KT's Laboratory has been financially supported by Neo Pharma Japan Co., Ltd. KT is a scientific advisor and a major stockholder of NPT Co., Ltd, and a minor stockholder of Oncolys BioPharma Inc, Shinnihonseiyaku Co., Ltd., NPT Co., Ltd, and SymBio Pharmaceuticals Co., Ltd. HI receives remuneration from Jocavio Inc. as an advisor, is a stockholder in Jocavio Inc. SM is a stockholder of NPT Co., Ltd. KT, HI and SM hold a patent on CVA11 [PCT/UP2O13A061686, PCT/JP2013/061686]. The other authors have no conflict of interest.